Pharmaceuticals Delivery in Ireland. Getting a Bigger Bang for the Buck
AbstractNo abstract is available for this item.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoThis book is provided by Economic and Social Research Institute (ESRI) in its series Research Series with number RS24 and published in 2012.
Note: Publisher: ESRI
Contact details of provider:
Postal: Whitaker Square, Sir John Rogerson's Quay, Dublin 2
Phone: (353-1) 863 2000
Fax: (353-1) 863 2100
Web page: http://www.esri.ie
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Delnoij, Diana & Brenner, Gerhard, 2000. "Importing budget systems from other countries: what can we learn from the German drug budget and the British GP fundholding?," Health Policy, Elsevier, vol. 52(3), pages 157-169, July.
- Michael Barry & Lesley Tilson & Máirín Ryan, 2004. "Pricing and reimbursement of drugs in Ireland," The European Journal of Health Economics, Springer, vol. 5(2), pages 190-194, May.
- repec:esr:chaptr:jacb201058 is not listed on IDEAS
- Paraponaris, A. & Verger, P. & Desquins, B. & Villani, P. & Bouvenot, G. & Rochaix, L. & Gourheux, J. C. & Moatti, J. P. AU -, 2004. "Delivering generics without regulatory incentives?: Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names," Health Policy, Elsevier, vol. 70(1), pages 23-32, October.
- Panos Kanavos & Joan Costa-Font, 2005. "Pharmaceutical parallel trade in Europe: stakeholder and competition effects," Economic Policy, CEPR & CES & MSH, vol. 20(44), pages 751-798, October.
- Valérie Paris & Elizabeth Docteur, 2008. "Pharmaceutical Pricing and Reimbursement Policies in Germany," OECD Health Working Papers 39, OECD Publishing.
- Mark Dusheiko & Hugh Gravelle & Rowena Jacobs & Peter Smith, 2003.
"The Effects of Budgets on Doctors Behaviour: Evidence from a Natural Experiment,"
The Centre for Market and Public Organisation
03/064, Department of Economics, University of Bristol, UK.
- Mark Dusheiko & Hugh Gravelle & Rowena Jacobs & Peter C Smith, . "The Effect of Budgets on Doctor Behaviour: Evidence From A Natural Experiment," Discussion Papers 03/04, Department of Economics, University of York.
- Lesley Tilson & Aisling OLeary & Cara Usher & Michael Barry, 2010. "Pharmacoeconomic Evaluation in Ireland: A Review of the Process," PharmacoEconomics, Springer Healthcare | Adis, vol. 28(4), pages 307-322.
- Brick, Aoife & Nolan, Anne & O'Reilly, Jacqueline & Smith, Samantha, 2010. "Resource Allocation, Financing and Sustainability in the Health Sector," Papers RB2010/3/1, Economic and Social Research Institute (ESRI).
- Lundin, Douglas, 2000. "Moral hazard in physician prescription behavior," Journal of Health Economics, Elsevier, vol. 19(5), pages 639-662, September.
- Dag Dalen & Kari Furu & Marilena Locatelli & Steinar Strøm, 2011.
"Generic substitution: micro evidence from register data in Norway,"
The European Journal of Health Economics,
Springer, vol. 12(1), pages 49-59, February.
- Dalen Gag Morten & Furu Kai & Locatelli Marilena & Strom Steinar, 2009. "Generic substitution. Micro evidence from register data in Norway," Department of Economics and Statistics Cognetti de Martiis. Working Papers 200901, University of Turin.
- Paul Gorecki, 2011. "Do you believe in magic? Improving the quality of pharmacy services through restricting entry and aspirational contracts, the Irish experience," The European Journal of Health Economics, Springer, vol. 12(6), pages 521-531, December.
- Eric de Laat & Rudy Douven & Esther Mot & F. Windmeijer, 2004.
"Pharmaceutical promotion and GP prescription behaviour,"
CPB Discussion Paper
30, CPB Netherlands Bureau for Economic Policy Analysis.
- Frank Windmeijer & Eric de Laat & Rudy Douven & Esther Mot, 2006. "Pharmaceutical promotion and GP prescription behaviour," Health Economics, John Wiley & Sons, Ltd., vol. 15(1), pages 5-18.
- Honohan, Patrick & Donovan, Donal & Gorecki, Paul & Mottiar, Rafique, 2010. "The Irish Banking Crisis: Regulatory and Financial Stability Policy," MPRA Paper 24896, University Library of Munich, Germany.
- Lambrelli, Dimitra & O'Donnell, Owen, 2011. "The impotence of price controls: Failed attempts to constrain pharmaceutical expenditures in Greece," Health Policy, Elsevier, vol. 101(2), pages 162-171, July.
- Nicolas Bloom & John Van Reenen, 1998. "Regulating drug prices: where do we go from here?," Fiscal Studies, Institute for Fiscal Studies, vol. 19(3), pages 321-342, August.
- Aoife Brick & Anne Nolan & Jacqueline O’Reilly & Samantha Smith, 2012. "Conflicting Financial Incentives in the Irish Health-Care System," The Economic and Social Review, Economic and Social Studies, vol. 43(2), pages 273â301.
- Duffy, David & Durkan, Joe & O'Sullivan, Cormac, 2012. "Quarterly Economic Commentary, Winter 2011/Spring 2012," Forecasting Report, Economic and Social Research Institute (ESRI), number QEC20121, March.
- Duffy, David & Durkan, Joe & Casey, Eddie, 2012. "Quarterly Economic Commentary, Summer 2012," Forecasting Report, Economic and Social Research Institute (ESRI), number QEC20122, March.
- Layte, Richard & Nolan, Anne, 2013. "Income-Related Inequity in the Use of GP Services: A Comparison of Ireland and Scotland," Papers WP454, Economic and Social Research Institute (ESRI).
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Sarah Burns).
If references are entirely missing, you can add them using this form.